Abu-Eid et al. [24, 29] found that PI3K inhibitor and AKT inhibitor of PI3K/AKT/AP-1 pathway can inhibit the proliferation of Treg cells, thereby enhancing the body's antitumor immune response and inhibiting tumor growth. Here, AKT1 is linked to neoplasm.